Nabisar COUGH SYRUP
Nabisar COUGH SYRUP : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL19106048T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- CAMBRIDGE BIOTEK SDN BHD
- Manufacturer
- CAMBRIDGE BIOTEK SDN BHD
- Registration period starting
- 2024-11-07
- Published validity end
- 2029-11-07
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Malpighia glabra | Malpighia glabra[2.5 mg,1 ml] | Not identified |
| Hedera helix | Hedera helix[0.4 mg,1 ml] | Not identified |
| Thymus vulgaris | Thymus vulgaris[12 mg,1 ml] | Not identified |
| Piper longum | Piper longum[1 mg,1 ml] | Not identified |
| Mentha piperita | Mentha piperita[1 mg,1 ml] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Malpighia glabra[2.5 mg,1 ml],Hedera helix[0.4 mg,1 ml],Thymus vulgaris[12 mg,1 ml],Piper longum[1 mg,1 ml],Mentha piperita[1 mg,1 ml]
- Valid until
- 2029-11-07
- Registration date
- 2024-11-07
- Published description
- NATURAL PRODUCT
- Licence holder
- CAMBRIDGE BIOTEK SDN BHD
- Producer
- CAMBRIDGE BIOTEK SDN BHD
- Published name
- Nabisar COUGH SYRUP
- Published reference
- 201902141808T
- Registration number
- MAL19106048T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL19106048T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Thymus vulgaris
Read the warning, when it applies and the studies cited
THYME - THYMUS VULGARIS - Buccal
Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
THYME - THYMUS VULGARIS - Oral
Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Health Canada monograph dated 26 June 2026
THYME - THYMUS VULGARIS - Topical
Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
- Mentha piperita
Read the warning, when it applies and the studies cited
PEPPERMINT - MENTHA X PIPERITA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Essential oil.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: Essential oil.
When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.